Call for more patient-centered drug development in oncology — NEJM

In an article in the New England Journal of Medicine (NEJM), published online on 3 July 2013, Dr Ethan Basch highlights the lack of information on how a drug will make patients feel in the US label of most new cancer drugs.  … Continue reading

Pfizer’s tofacitinib appears to be as effective as Humira in Rheumatoid Arthritis (RA)

Pfizer provided details of tofacitinib data to be presented at the American College of Rheumatology (ACR) 2011 congress on 8 September.  The congress will be held on 5-9 November in Chicago. Tofacitinib is a novel, oral Janus kinase (JAK) inhibitor under … Continue reading